Simple Education essential guides Advances in Coronary Physiology is the premiere international course in coronary physiology. This is the 6th year this 5* rated course has been run which has quickly become established as the premier global interventional course in state-of-the-art coronary physiology. The course provides all you need to know to understand coronary physiology from learning the background basics of coronary physiology, to understanding the clinical trial data and implementation of coronary physiology in the catheter laboratory.
Advances in Coronary Physiology course provides all you need to know to understand the basics of coronary physiology and what you need to do to implement coronary physiology into the cardiac catheter laboratory.
Understanding the background of coronary physiology
Understanding of coronary blood flow regulation in unobstructed and obstructed coronary arteries
Learn what you need to know to implement iFR and FFR in your laboratory
Learn about the guidelines for appropriate use and reimbursement
| 09.00-09.10 | Welcome and introductions Justin Davies, Course Co-Director |
| 09.10-09.20 | Hot topics in coronary physiology? DEFINE-FLAIR iFR SwedeHeart Compare Acute Syntax II Justin Davies |
| 09.25-09.45 | Pressure derived indices of stenosis severity Ricardo Petraco |
| 09.50-10.30 | Live case transmission I Operator: Javier Escaned Clinico San Carlos, Madrid, Spain Moderator: Justin Davies |
| 10.35-10.55 | Coffee break |
| 10.55-11.15 | Understanding mechanisms of regulation of resting and hyperaemic blood flow Christopher Cook |
| 11.20-11.25 | Getting the most out of our Advances in Coronary Physiology Courses: online-resources, and certification Juliet Nilsson |
| 11.30-11.50 | DEFINE-FLAIR and iFR SwedeHeart study design and results Carlo Di Mario |
| 11.55-12.10 | Flow based indices of stenosis severity Justin Davies |
| 12.10-13.10 | Lunch |
| 13.10-13.30 | Combined, patient-level pooled analysis of DEFINE-FLAIR and iFR SwedeHeart and safety of deferral in stable coronary disease and ACS. Does flow underlie the results? Sayan Sen |
| 13.35-13.55 | Health Economic assessment using iFR and FFR to guide revascularization decision-making Justin Davies |
| 14.00-14.15 | How to perform iFR and FFR, and best-practice measurement tips and tricks Ricardo Petraco |
| 14.20-14.50 | Coffee break |
| 14.55-15.15 | Understanding mismatch between iFR and FFR from DEFINE-FLAIR and iFR SwedeHeart using pressure and flow exercise physiology data. Christopher Cook |
| 15.20-15.40 | DEFINE-FLAIR and iFR SwedeHeart: Implication for guidelines and evaluation of coronary ischaemia Carlo Di Mario |
| 15.45-16.00 | Safety of deferral in LAD, and non-LAD vessels using iFR and FFR guide approach. Sayan Sen |
| 16.05-16.20 | Should stenting be used at all? Results and impact from ORBITA Rasha Al-Lamee |
| 16.30-17:30 | Reception |
| 17.40 | Close of the day |
| 09.00-09.10 | Welcome and introductions Justin Davies&Javier Escaned, Course Directors |
| 09.10-09.25 | Lessons learned from the 2-year results of SYNTAX II Javier Escaned |
| 09.30-10.10 | Live case transmission II Operator: Sayan Sen, Ricardo Petraco Hammersmith Hospital Moderators: Javier Escaned, Sukhjinder Nijjer |
| 10.15-10.25 | Coffee break |
| 10.25-10.40 | Should we be treating a number? Moving from vessel level ischaemia to stenosis level assessment. Are we missing physiologically significant stenoses? Justin Davies |
| 10.45-11.00 | Understanding SyncVision Co-registration and why it’s important to distinguish between focal and diffuse coronary disease Sukhjinder Nijjer |
| 11.05-11.25 | Using iFR Co-registration to plan revascularization decision-making: Cases examples Sukhjinder Nijjer |
| 11.30-11.45 | Should we be using a dichotomous cutpoint? And what is the meaning of an FFR>0.80 Javier Escaned |
| 11.50-12.05 | Using digital algorithms , and AI to improve physiological measurement and data interpretation. Justin Davies |
| 12.10-13.10 | Lunch |
| 13.10-13.30 | Post PRAMI, Culprit, and Compare Acute, what role does physiology have in coronary revascularization? What other studies are needed? Javier Escaned |
| 13.35-13.50 | Is it still too early to use CT-FFR and angio-FFR in the catheter laboratory in 2018? Christopher Cook |
| 13.55-14.10 | How does right arterial pressure impact physiological assessment? And what is the role of Navvus FFR catheter? Ricardo Petraco |
| 14.15-14.30 | Physiological assessment in coronary stenosis pre TAVI Sukhjinder Nijjer |
| 14.35-15.00 | Summary and Q&A session Justin Davies |
| 15.30 | Close of the meeting |
If you have any questions about the course please contact our course manager:
Lenka Navratilova: aps@heart123.co.uk